Jeena Sikho Lifecare LtdQ1 FY24Pharmaceuticals & Biotechnology

Jeena Sikho Lifecare Ltd

Q1 FY24 Earnings Call Analysis

Management growth scorecard

Revenue

Category 1

Margin

Category 1

Fundraise

N/A

Order

Yes

Capex

Yes

4 of 4 growth signals are positive — a strong management growth story.

Revenue guidance

Category 1

→Targeting 55% occupancy in FY '25, leading to revenue of around INR 450 crores.
→Planning to add 500 new hospital beds by March 2025, with incremental revenue expected from these additions.
→Revenue expected to reach INR 600-650 crores by FY '26 with 85% occupancy on older beds and 35% on 500 new beds.
→PAT margin projected to exceed 25% due to controlled expenses despite expansion.
→Medicine vertical grew by 32% YoY, with plans to launch 10 OTC patented formulas priced between INR 150-600.
→Focus on increasing patient awareness about cashless health insurance since April 2024, aiding revenue growth.
→Long-term plan to have 3,000 beds in 3 years and over 4,000 beds in 5 years, aiming to become India’s number one Ayurvedic healthcare company.
→Expanding in new segments such as infertility, heart, and liver diseases.
→International expansion underway with plans for centers in Mauritius and approvals in 112 countries.

Category 1

→Target revenue for FY25 is around INR 450 crores with a PAT margin of approximately 25%.
→Occupancy increase from current 37% to 55% expected to drive 50% growth in profit; potential to triple profit if occupancy reaches 80%.
→Plans to add 500 new beds by March 2025, with some beds operational mid-year, enhancing revenue and profit.
→Long-term target to scale to 3,000 beds in 3 years and over 4,000 beds in 5 years, supporting sustained growth.
→EBITDA and profit margins are improving, with FY24 showing 29% EBITDA margin and 21% PAT margin.
→Profit has grown faster than revenue, e.g., profit grew 3.75 times from 2022 to 2023 while revenue doubled.
→Expansion facilitated by government backing, increased insurance cashless benefits, and strong product portfolio growth.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Jeena Sikho Lifecare Ltd and 1,400+ other companies.

→Manish Grover mentioned a budget of around INR 7.75 crores for adding a 300-bed hospital in Meerut, Chandigarh, Rajpura.
→For adding 500 beds over the next 2-3 years, total capex is estimated between INR 15 to 20 crores.
→The company primarily takes hospitals on rent and only invests in interiors, reducing upfront capex burden.
→There is no explicit mention of new fundraising through debt or equity in the discussed transcript.
→The expansion and capex appear to be managed through operational cash flows or owner contributions rather than new fundraising.
→The company plans to increase bed capacity by 500-600 beds every year over the next 5 years, indicating ongoing capital requirements, but no direct fundraising announcements.

Yes

→The transcript does not explicitly mention current or expected order book or pending orders in numeric terms.
→However, Manish Grover discussed a robust expansion plan including adding 500 new beds by March 2025, increasing total beds from around 1,300 to 1,800.
→He also mentioned plans to open 15 new hospitals within the year, focusing on areas with higher patient inquiries and government healthcare plans.
→OTC medicine launches are planned within 3 to 6 months after market surveys, targeting chronic diseases with potentially large patient bases.
→The company is aiming to increase hospital occupancy from 37% to 55% in FY25, which would significantly boost revenues.
→Government support includes cashless health insurance starting April 2024, expected to improve patient inflow and order flow.
→Overall, the business pipeline looks strong with ongoing capacity additions and product launches, implying a growing order inflow though exact order book numbers are not disclosed.

Yes

→Planned addition of 500 new beds by FY2025, with capex of approximately INR3 lakh per bed (INR15 crores to INR20 crores for 500 beds).
→Specific hospital investments include 300 beds in Meerut, Chandigarh, Rajpura with a budget of around INR7.75 to 9 crores.
→Continued focus on adding 500-600 beds every year for the next 3-5 years, aiming to reach 3,000 beds in 3 years and above 4,000 beds in 5 years.
→New hospitals planned in Uttar Pradesh (Meerut - 350 beds, Lucknow - 100 beds, plus Kanpur, Agra, Banaras, Saharanpur, and potential hospital in Noida).
→Capex spent in FY24 was INR80 crores.
→No direct ownership of hospitals; properties are taken on rent with capex focused primarily on interiors.
→Strategic emphasis on NABH accreditation and cashless treatment integration in Ayurveda.
→Expansion plans include entering international markets like Mauritius, Dubai, and Canada with clinics/hospitals.

How does Jeena Sikho Lifecare Ltd rank vs peers in Pharmaceuticals & Biotechnology?

Pro feature

1Jeena Sikho Lifecare Ltd

Rev 1Mar 1

See full Pharmaceuticals & Biotechnology sector rankings

Want more stocks like Jeena Sikho Lifecare Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.